Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells

Journal of Virology

Volumn 73, Issue 1, 1999, Pages 334-342

  Redchenko, I V ^a   Rickinson, A B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL SPECIFICITY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0032889253     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.1.334-342.1999     Document Type: Article

References (12)

1. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs. Nature 392:86-89.
2. 1a. Annels, N., and A. B. Rickinson. Unpublished data.
3. Apolloni, A., D. Moss, R. Stumm, S. Burrows, A. Suhrbier, I. Misko, C. Schmidt, and T. Sculley. 1992. Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus. Eur. J. Immunol. 22:183-189.
4. Bachmann, M. F., M. B. Lutz, G. T. Layton, S. J. Harris, T. Fehr, M. Rescigno, and P. Ricciardicastagnoli. 1996. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8(+) cytotoxic T lymphocytes. Eur. J. Immunol. 26:2595-2600.
5. Bakker, A. B. H., G. Marland, A. J. Deboer, R. J. F. Huijbens, E. H. J. Danen, G. J. Adema, and C. G. Figdor. 1995. Generation of anti-melanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res. 55:5330-5334.
6. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
7. Bender, A., M. Sapp, G. Schuler, R. M. Steinman, and N. Bhardwaj. 1996. Improved methods for the generation of dendritic cells from non-proliferating progenitors in human blood. J. Immunol. Methods 196:121-135.
8. Blake, N., S. P. Lee, I. Redchenko, W. A. Thomas, N. Steven, A. Leese, P. M. Steigerwald-Mullen, M. G. Kurilla, L. Frappier, and A. B. Rickinson. 1997. Human CD8(+) T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 7:791-802.
9. Bogedain, C., H. Wolf, S. Modrow, G. Stuber, and W. Jilg. 1995. Specific cytotoxic T-lymphocytes recognize the immediate-early transactivator ZTA of Epstein-Barr virus. J. Virol. 69:4872-4879.
10. Brooks, J. M., R. A. Colbert, J. P. Mear, A. Leese, and A. B. Rickinson. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex. J. Immunol., in press.
11. Brooks, J. M., R. J. Murray, W. A. Thomas, M. G. Kurilla, and A. B. Rickinson. 1993. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J. Exp. Med. 178:879-887.
12. Brossart, P., and M. J. Bevan. 1997. Presentation of exogenous protein antigens on major histocompatability complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood 90:1594-1599.